X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/apr-applied-pharma-research-a-subsidiary-of-relief-therapeutics-is-a-finalist-in-the-2022-rare-disease-international-film-festival-301683678.html
https://www.accesswire.com/693092/Relief-Therapeutics-Wholly-Owned-Subsidiary-APR-Applied-Pharma-Research-Signs-an-Agreement-To-Acquire-Rights-to-Commercialize-a-Novel-Dosage-Form-for-the-Treatment-of-PKU
https://finance.yahoo.com/news/relief-therapeutics-wholly-owned-subsidiary-052000724.html
https://www.biospace.com/article/releases/relief-therapeutics-reports-two-publications-of-positive-data-on-nexodyn-r-aos-for-hard-to-heal-ulcers/?s=71
https://www.biospace.com/article/releases/relief-therapeutics-wholly-owned-subsidiary-apr-applied-pharma-research-launches-pku-golike-r-krunch-in-germany-and-italy/?s=71
https://www.pharmiweb.com/press-release/2021-06-29/relief-and-apr-applied-pharma-research-sign-and-close-definitive-agreement-for-relief-to-acquire-all
https://www.biospace.com/article/releases/relief-and-apr-applied-pharma-research-sign-and-close-definitive-agreement-for-relief-to-acquire-all-outstanding-shares-of-apr/?s=79
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-apr-od031-for-the-treatment-of-phenylketonuria-pku-301030421.html
Market Place
Share 
